Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dooijewaard

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Thrombosis and Haemostasis|October 31, 1988
Plasminogen activators in the intestine of patients with inflammatory bowel diseaseP A de Bruin, G Crama-Bohbouth, H W Verspaget, et al.
Clinical Pharmacology and Therapeutics|November 1, 1996
Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activatorJ M van Griensven, L G Huisman, T Stuurman, et al.
Cancer Research|August 15, 1988
Plasminogen activator profiles in neoplastic tissues of the human colonP A de Bruin, G Griffioen, H W Verspaget, et al.
Thrombosis and Haemostasis|December 1, 1995
Identification and genetic analysis of a common molecular variant of histidine-rich glycoprotein with a difference of 2kD in apparent molecular weightB C Hennis, P A van Boheemen, S Wakabayashi, et al.
Thrombosis and Haemostasis|November 10, 1992
Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exerciseA de Boer, C Kluft, G Dooijewaard, et al.
Thrombosis and Haemostasis|April 7, 1987
Increased plasminogen activator inhibition levels in malignancyE de Jong, E A Knot, D Piket, et al.
Gastroenterology|December 1, 1991
Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesisC F Sier, H W Verspaget, G Griffioen, et al.
Gastroenterology|November 1, 1994
Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasisC F Sier, H J Vloedgraven, S Ganesh, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Thrombosis and Haemostasis|October 31, 1988
Plasminogen activators in the intestine of patients with inflammatory bowel diseaseP A de Bruin, G Crama-Bohbouth, H W Verspaget, et al.
Clinical Pharmacology and Therapeutics|November 1, 1996
Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activatorJ M van Griensven, L G Huisman, T Stuurman, et al.
Cancer Research|August 15, 1988
Plasminogen activator profiles in neoplastic tissues of the human colonP A de Bruin, G Griffioen, H W Verspaget, et al.
Thrombosis and Haemostasis|December 1, 1995
Identification and genetic analysis of a common molecular variant of histidine-rich glycoprotein with a difference of 2kD in apparent molecular weightB C Hennis, P A van Boheemen, S Wakabayashi, et al.
Thrombosis and Haemostasis|November 10, 1992
Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exerciseA de Boer, C Kluft, G Dooijewaard, et al.
Thrombosis and Haemostasis|April 7, 1987
Increased plasminogen activator inhibition levels in malignancyE de Jong, E A Knot, D Piket, et al.
Gastroenterology|December 1, 1991
Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesisC F Sier, H W Verspaget, G Griffioen, et al.
Gastroenterology|November 1, 1994
Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasisC F Sier, H J Vloedgraven, S Ganesh, et al.
Pageof 5